Status:
UNKNOWN
Kinesiotape on Balance in With Multiple Sclerosis
Lead Sponsor:
Firat University
Conditions:
Individuals With Multiple Sclerosis
With Ataxia Symptoms
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligodendrocyte and axon damage. Research continues on the autoimmune, infe...
Detailed Description
Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligodendrocyte and axon damage. Research continues on the autoimmune, infe...
Eligibility Criteria
Inclusion
- with ataxia symptoms with a diagnosis of multiple sclerosis No attacks in the last 3 months
Exclusion
- Having other illnesses that may affect the balance allergic to kinesiotape
Key Trial Info
Start Date :
November 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 6 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05341895
Start Date
November 22 2021
End Date
May 6 2022
Last Update
April 22 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Furkan Bilek
Elâzığ, Turkey (Türkiye), 23100
2
Fırat university
Elâzığ, Turkey (Türkiye), 23100